Progenics Pharmaceuticals Inc. (PGNX) jumped 6.18% or 0.47 to $8.07. It is near 1.13 million shares traded, which is 115.6% compare to the average total volume 976850. The market cap of PGNX is $594.91 million. The year to date change is 23.58%. The 52 week price range is from $4.6 to $8.63. Price of PGNX have changed 1.20% during last week. It have changed 16.74% over last month, 13.77% over last 3 months, 31.49% over last 6 months and 18.56% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PGNX is 7.27. It is -9.91% below current price. The 200-day Moving Averages for PGNX is 6.54. It is -18.96% below current price. The 52-week High is 8.63. It is 6.94% from the current price. The 52-week Low is 4.6. It is -43.00% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of PGNX is 11.55 on 2018-05-15. Short % to float is 14.30%. There are some statistics of PGNX. It is has market cap $594.91 million. The share outstanding is 73.72 million. The average volume is 976850. The revenue is 5.46M. It has 212.24M cash and 99.19M in debt. The percent of top 15 Institution holding is 78.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PGNX is -58.66%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PGNX is -27.30%.